Sirolimus in renal transplantation: analysis of safety and efficacy in a nonprotocol conversion group.
Gois, P H F
Sirolimus in renal transplantation: analysis of safety and efficacy in a nonprotocol conversion group. [electronic resource] - Transplantation proceedings Oct 2012 - 2348-51 p. digital
Publication Type: Journal Article
1873-2623
10.1016/j.transproceed.2012.07.010 doi
Biomarkers--blood
Chi-Square Distribution
Creatinine--blood
Drug Substitution
Graft Rejection--blood
Graft Survival--drug effects
Humans
Immunosuppressive Agents--administration & dosage
Kaplan-Meier Estimate
Kidney Transplantation--adverse effects
Proteinuria--etiology
Retrospective Studies
Risk Assessment
Risk Factors
Sirolimus--administration & dosage
Time Factors
Treatment Outcome
Sirolimus in renal transplantation: analysis of safety and efficacy in a nonprotocol conversion group. [electronic resource] - Transplantation proceedings Oct 2012 - 2348-51 p. digital
Publication Type: Journal Article
1873-2623
10.1016/j.transproceed.2012.07.010 doi
Biomarkers--blood
Chi-Square Distribution
Creatinine--blood
Drug Substitution
Graft Rejection--blood
Graft Survival--drug effects
Humans
Immunosuppressive Agents--administration & dosage
Kaplan-Meier Estimate
Kidney Transplantation--adverse effects
Proteinuria--etiology
Retrospective Studies
Risk Assessment
Risk Factors
Sirolimus--administration & dosage
Time Factors
Treatment Outcome